TREPaed_10, TREPaed_5, TREPaed_0.5, TREPaed_2.5, TREPaed_1
TREPaed
Phase 3 small_molecule active
Quick answer
TREPaed_10, TREPaed_5, TREPaed_0.5, TREPaed_2.5, TREPaed_1 for Pulmonary Arterial Hypertension (PAH) is a Phase 3 program (small_molecule) at AOP Orphan Pharmaceuticals GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AOP Orphan Pharmaceuticals GmbH
- Indication
- Pulmonary Arterial Hypertension (PAH)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active